| dc.contributor.author | Jana, S S | |
| dc.contributor.author | Bharali, D J | |
| dc.contributor.author | Mani, Prashant | |
| dc.contributor.author | Maitra, Amarnath | |
| dc.contributor.author | Gupta, C M | |
| dc.contributor.author | Sarkar, D P | |
| dc.date.accessioned | 2008-10-23T20:54:15Z | |
| dc.date.available | 2008-10-23T20:54:15Z | |
| dc.date.issued | 2002 | |
| dc.identifier.citation | FEBS Letters 515, 184- 189 | en |
| dc.identifier.uri | http://hdl.handle.net/123456789/206 | |
| dc.description.abstract | Hydrogel nanoparticles of cross-linked polyvinylpyrrolidone (PVP-NP) (35-50 nm in diameter) containing fluoresceinated dextran (FITC-Dx) were encapsulated in reconstituted Sendai viral envelopes containing only the fusion (F) protien (F- virosomes). Incubtion of these loaded F- virosmes with human hepatoblastoma cells (HepG2) in culture cytoplasm, as inferred froom the ability of cells tointernalize FITC-Dx loaded PVP-NP(PVP-NP) in the presence of azide (an inhibitor of the endocytotic process). Introduction of PVP-NP into the HelpG2 cells wasw assured by selctive accumulation of FITC fluorescence in the cytosolic compartment. The structural integrity of the internalzed PVP-NP was also confirmed by fluorescence microscopy and ultracentrifugation analysis. The potential usefulness of PVP-NP -mediated cytosolic release of water soluble drugs boyh in vitro and in vivo has been established for the first time. | en |
| dc.format.extent | 3058853 bytes | |
| dc.format.mimetype | application/pdf | |
| dc.language.iso | en | en |
| dc.subject | Hydrogel nanoparticle | en |
| dc.subject | Sendai virus | en |
| dc.subject | Virosome | en |
| dc.subject | Drug delivery | en |
| dc.subject | Targeted cytosolic delivery | en |
| dc.subject | Controlled release | en |
| dc.title | Targeted cytosolic delivery of hydrogel nanoparticles into HepG2 cells through engineered Sendai viral envelopes | en |
| dc.type | Article | en |